Medication
Ended Awarded
- Contract number
- 36C24621N0326
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,035
Award facts
- Contract value 100% obligated
- $10,034.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6, awarded a firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for medication on November 9, 2020, with a ceiling value of $10,034.63 and an ultimate completion date of November 24, 2020. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize any set-aside designation. The place of performance is Potomac, Maryland. Otsuka America Pharmaceutical Inc., headquartered in Rockville, Maryland, is a for-profit pharmaceutical manufacturer specializing in complex pharmaceutical products and has established itself as a primary supplier of specialty medications to the VA's Veterans Health Administration.
This delivery order represents a task order issued against Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $83.3 million and effective through March 26, 2026. The company supplies specialized pharmaceutical treatments, including Jynarque (tolvaptan) for treating autosomal dominant polycystic kidney disease and hyponatremia, to multiple VA Integrated Service Networks across the United States. The delivery order structure allows VA facilities to efficiently procure critical pharmaceutical treatments for veterans while maintaining cost controls through firm fixed-price arrangements.
Quick answers
Who was awarded contract 36C24621N0326?
36C24621N0326 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on November 9, 2020.
How much is contract 36C24621N0326 worth?
The government has obligated $10,035 on 36C24621N0326.
Is contract 36C24621N0326 an order under another contract?
Yes. 36C24621N0326 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24621N0326 competed?
The extent of competition for 36C24621N0326 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award